Pathogenesis of Non-Hodgkin's Lymphoma

The understanding of the molecular pathogenesis of non-Hodgkin's lymphomas (NHL) has significantly improved in recent years. Advances in molecular biology and genetics lead to the identification and characterization of several oncogenic pathways involved in lymphomagenesis. This knowledge will...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 29; no. 14; pp. 1803 - 1811
Main Authors Nogai, Hendrik, Dörken, Bernd, Lenz, Georg
Format Journal Article
LanguageEnglish
Published United States American Society of Clinical Oncology 10.05.2011
Subjects
Online AccessGet full text
ISSN0732-183X
1527-7755
1527-7755
DOI10.1200/JCO.2010.33.3252

Cover

More Information
Summary:The understanding of the molecular pathogenesis of non-Hodgkin's lymphomas (NHL) has significantly improved in recent years. Advances in molecular biology and genetics lead to the identification and characterization of several oncogenic pathways involved in lymphomagenesis. This knowledge will ultimately lead to improved diagnostic and therapeutic strategies for patients with NHL. This review summarizes current concepts of the molecular pathogenesis of the most common NHL subtypes, with a special emphasis on diffuse large B-cell lymphoma, the most common lymphoma subtype.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0732-183X
1527-7755
1527-7755
DOI:10.1200/JCO.2010.33.3252